p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses

Clinical cancer research : an official journal of the American Association for Cancer Research

Volumn 20, Issue 17, 2014, Pages 4459-4470

  Hardwick, Nicola R ^a   Carroll, Mary ^a   Kaltcheva, Teodora ^a   Qian, Dajun ^a   Lim, Dean ^a   Leong, Lucille ^a   Chu, Peiguo ^a   Kim, Joseph ^a   Chao, Joseph ^a   Fakih, Marwan ^a   Yen, Yun ^a   Espenschied, Jonathan ^a   Ellenhorn, Joshua D I ^a   Diamond, Don J ^a   Chung, Vincent ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PROTEIN P53; TP53 PROTEIN, HUMAN;

AGED; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PHASE 1 CLINICAL TRIAL;

AGED; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84928965963     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-3361     Document Type: Article

References (0)